Instytut Medycyny Pracy i Zdrowia Środowiskowego,
Dyrektor: prof. nadzw. dr hab. Leszek Wieczorek
2
Katedra i Zakład Higieny Uniwersytetu Medycznego
we Wrocławiu,
Kierownik: prof. dr hab. n. med. K. Pawlas
Corresponding author
Henryka Langauer-Lewowicka
Prof. dr hab. n. med. Henryka Langauer-Lewowicka
Instytut Medycyny Pracy i Zdrowia Środowiskowego
ul. Kościelna 13, 41-200 Sosnowiec
tel. 32 634 12 00
This paper presents information on the growing application and possible impacts of nanosilverparticles on human health and environment. Silver nanoparticles are the most frequent commercialized nanomaterial. They are used in a number of strategic areas including energy, electronics, medicine and biotechnology. Currently little is known about the toxicity of silver nanoparticles or about the mechanism of adverse effect. The potential risk associated with the application of engineered silver nanoparticles have been videly delated in recent years.
REFERENCES(31)
1.
Russel A.D., Hugo W.B.: Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 35-370.
Van de Voorde, Nijsten K., Schelfhout T., Moorkens K. et al.: Long-term use of silver containing nose-drops resulting in systemic argyria. Acta Clin Belg 2005; 60: 33-35.
Hackenberg S., Scherzed A., Kessler M. et al.: Silver nanoparticles: Evaluation on DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicology Letters 2011; 201: 27-33.
Noguerira P.F.M., Paino L.M.M., Zucolotto V.: Nanosilver: Properties, Applications and Impacts on Health and Environment. Vigilancia Sanitaria en Debate 2013; 1(4): 57-68.
Chaloupka K., Malam Y., Seifalian M.: Nanosilver as a new generation of nanoproduct in biomedical applications. Trends in Biotechnology 2010; 28: 580-588.
Marambio-Jones G., Hosek E.M.V.: A review of the antibacterial effects of silver nanomaterials and potential implication for humans health and the environment. J Nanopart R 2010; 12: 1531-1551.
Dimkpa C.O., Calder A., Gajjar P. et al.: Interaction of silver nanoparticles with environmentally beneficial bacterium Psedomonas chloraphis. J Hazardous Metarials 2011; 188: 428-435.
Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A. et al.: Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009; 3(2): 109-138.
Ji J.H., Jung J.H., Kim S.S. et al.: Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2007; 19: 857-871.
Lankveld D.P.K., Oomen A.G., Krystek P. et al.: The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010; 31: 8350-8351.
Lee K.J., Nallathamby P.D., Browning L.M. et al.: In vivo imaging transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. Am Chem Soc 2007; 1(2): 133-143.
Stebounova L., Adamcakova-Dodd A., Kim J.S. et al.: Nanosilver induces minimal lung toxicity or inflammation in a subacute murina inhalation model. Particle and Fibre Toxicology 2011; 8: 5, 1-12.
Park J., Lim D.H., Lim H.J. et al.: Size dependent Macrophage Responsens and Toxicological Effects of Ag nanoparticles. Chem Commun 2011; 47: 4382-4384.
Panyala N.R., Pena-Mendez M.P., Havel J.: Silver or silver nanoparticles: a hazardous threat to the environment and human health. J Appl Biomed 2008; 6: 117-129.
Park Margriet V.D.Z., Neigh A.M., Vermeulen J.P. et al.: The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011; 32: 9810-9817.
Schäfer B., vom Brocke J., Epp A. et al.: State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BJR in 2012. Arch Toxicol DOI: 10, 1007/00204-013-1083-8.
Trop M., Nowak M., Rodl S. et al.: Silver coated dressing acticoat caused raised liver enzymes and argyria – like symptoms in burn patients. J Trauma Injury Infect Crit Care 2006; 60: 648-652.
Jankowska E., Łukaszewska J.: Potencjalne narażenie na nanocząstki srebra podczas rozpylania preparatu do czyszczenia klimatyzacji. Medycyna Pracy 2013; 64(1): 57-67.
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Modified Opinion (after public consultation) on adopted by the SCENIHR during the 10th plenary meeting of 10 March 2006 after public consultation.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.